Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
U.S. Life Expectancy Dropped Since 2014 for Working-Age Adults
TUESDAY, Nov. 26, 2019 (HealthDay News) -- U.S. life expectancy increased from 1959 to 2016 but has been decreasing since 2014, according to research published in the Nov. 26 issue of the Journal of the American Medical Association.
Maternal Efavirenz May Up Risk for Microcephaly Among Offspring
MONDAY, Nov. 25, 2019 (HealthDay News) -- In utero exposure to efavirenz is associated with an increased risk for microcephaly among children who are HIV-exposed but uninfected, according to a study published online Nov. 15 in The Lancet HIV.
Electronic Health Record Usability Graded F by Physicians
FRIDAY, Nov. 22, 2019 (HealthDay News) -- The usability of current electronic health records (EHRs) is classified as unacceptable, with physician-rated EHR usability independently linked to the odds of burnout, according to a study published online Nov. 14 in the Mayo Clinic Proceedings.
Employee Premiums, Deductibles Eating Larger Share of Income
THURSDAY, Nov. 21, 2019 (HealthDay News) -- During the last decade, health care costs have eaten up a larger share of income for millions of middle-class Americans with employer coverage, according to Trends in Employer Health Care Coverage, 2008-2018, a Nov. 21 report from The Commonwealth Fund.
Distribution of Self-Test Kits Can Up HIV Awareness
TUESDAY, Nov. 19, 2019 (HealthDay News) -- Distribution of HIV self-tests among men who have sex with men (MSM) can increase testing and newly identified infections, according to a study published online Nov. 18 in JAMA Internal Medicine.
Bipartisan Bill to Curb Drug Costs Backed by White House
MONDAY, Nov. 18, 2019 (HealthDay News) -- A bipartisan Senate bill that would curb prescription drug costs is being backed by the Trump administration as a new poll shows that many Americans think the White House has done little to tackle the issue.
White House Wants Hospitals, Insurers to Provide Actual Costs of Care
MONDAY, Nov. 18, 2019 (HealthDay News) -- New rules requiring hospitals and insurers to disclose the actual prices for common tests and procedures before they are performed have been proposed by the Trump Administration.
Survey of U.S. Registered Nurses Points to Worsening Shortages
THURSDAY, Nov. 14, 2019 (HealthDay News) -- The 2019 AMN Healthcare Survey of Registered Nurses raises concerns about the outlook for the nursing profession in the United States.
Syringe Exchange Program Has Positive Impact on HIV Diagnoses
WEDNESDAY, Oct. 30, 2019 (HealthDay News) -- A syringe exchange program (SEP) has averted thousands of injection drug use (IDU)-associated HIV diagnoses over 10 years in Philadelphia and Baltimore, according to a study published in the Dec. 1 issue of the Journal of Acquired Immune Deficiency Syndrome.
Menopause Occurs at Median Age of 48 in Canadian Women With HIV
WEDNESDAY, Nov. 6, 2019 (HealthDay News) -- Canadian women with HIV have a median age of menopause of 48 years, with lower education and hepatitis C coinfection independently associated with menopause at <45 years, according to a study published online Nov. 6 in Menopause.
Medical Practices Burdened by Regulatory Requirements
TUESDAY, Nov. 5, 2019 (HealthDay News) -- The vast majority of group medical practices report that regulatory requirements, including prior authorization and quality payment programs, are burdensome, according to a survey released by the Medical Group Management Association.
Seriously Ill Medicare Beneficiaries Face Financial Hardship
MONDAY, Nov. 4, 2019 (HealthDay News) -- Seriously ill Medicare enrollees experience considerable financial distress, according to a report published in the November issue of Health Affairs.
Dr. Stephen Hahn Nominated to Head FDA
MONDAY, Nov. 4, 2019 (HealthDay News) -- Radiation oncology expert Stephen Hahn, M.D., has been nominated as the new U.S. Food and Drug Administration commissioner.
Recommendations Developed to Address Clinician Burnout
FRIDAY, Nov. 1, 2019 (HealthDay News) -- In Taking Action Against Clinician Burnout, a new report published online Oct. 23 by the National Academies of Sciences, Engineering, and Medicine, recommendations are presented to address clinician burnout.